Interestingly, the NAM HD treatment induced Nr1h2 expression (encoding LXRβ) (1.7-fold, p ˂ 0.05) without changing the expression of Nr1h3 (encoding LXRα) (Figure S4, panel (a)). Here, NR1H2 is linked to Huntington disease.